Skip to content
Screener

Zimmer Biomet Holdings ZBH Asia Pacific — Operating Income

Other geography segments

Americas
$546M+1.9%
EMEA
$151.1M-1.8%

Similar metrics at other companies

eGain logo
EGANAsia Pacific — Operating Income
-$1.63M-12.0%
Manhattan Associates logo
MANHAsia Pacific — Operating Income
$6.26M+11.7%
NuSkin Enterprises logo
NUSSoutheast Asia Pacific — Operating Income
$9.3M-23.4%
NetSol Technologies logo
NTWKAsia Pacific Region — Operating Income
$3.65M+1,477%
The Manitowoc Company logo
MTWMiddle East And Asia Pacific — Operating Income
$8.1M-28.9%
Apple logo
AAPLRest of Asia Pacific — Operating Income
$4.13B+38.2%

Other financials

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%
EPS (diluted)$1.03+33.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation

See full
Market cap$18.54B+5.3%
Enterprise value$25.6B+4.0%
P/E23×+1.6×
P/S2.2×-0.1×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Zimmer Biomet Holdings’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335044
Line itemAmericas / Three Months Ended June 30, 2026Americas / Three Months Ended June 30, 2025EMEA / Three Months Ended June 30, 2026EMEA / Three Months Ended June 30, 2025Asia Pacific / Three Months Ended June 30, 2026Asia Pacific / Three Months Ended June 30, 2025Total / Three Months Ended June 30, 2026Total / Three Months Ended June 30, 2025
Cost of products sold, excluding intangible asset amortization309.3292.7182.6166.6124.2117.6
Selling, general and administrative432.7385.2142.8136.0107.390.7
Research and development71.173.61.91.73.93.5
Segment profit$546.0$535.6$151.1$153.8$104.1$120.3$801.2$809.7
Corporate items311.7349.1
Intangible asset amortization163.4160.6
Other income (expense), net(1.9)(3.9)
Interest expense, net72.979.3

Item 1. Financial Statements

FAQ

What is Zimmer Biomet Holdings's asia pacific — operating income?
Zimmer Biomet Holdings (ZBH) reported asia pacific — operating income of $104.1M in Q2 2026.
How has Zimmer Biomet Holdings's asia pacific — operating income changed year-over-year?
Zimmer Biomet Holdings's asia pacific — operating income decreased by 13.5% year-over-year, from $120.3M to $104.1M.
What is the long-term trend for Zimmer Biomet Holdings's asia pacific — operating income?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's asia pacific — operating income has grown at a 1.4% compound annual growth rate (CAGR), from $419.2M to $442.9M.
What does asia pacific — operating income mean?
The profit or loss generated by the Asia Pacific segment after deducting cost of goods sold, SG&A, and R&D expenses from total revenue. This metric measures the core operational profitability of the regional business unit before interest and taxes. It is the primary indicator of the segment's ability to generate sustainable earnings.

Ask your AI about Zimmer Biomet Holdings's asia pacific — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude